DK1349855T3 - 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt - Google Patents
5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsaltInfo
- Publication number
- DK1349855T3 DK1349855T3 DK01272109T DK01272109T DK1349855T3 DK 1349855 T3 DK1349855 T3 DK 1349855T3 DK 01272109 T DK01272109 T DK 01272109T DK 01272109 T DK01272109 T DK 01272109T DK 1349855 T3 DK1349855 T3 DK 1349855T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridyl
- ethoxy
- benzyl
- amino
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0031524A GB0031524D0 (en) | 2000-12-22 | 2000-12-22 | Novel pharmaceutical |
GB0031526A GB0031526D0 (en) | 2000-12-22 | 2000-12-22 | Novel pharmaceuticals |
GB0031528A GB0031528D0 (en) | 2000-12-22 | 2000-12-22 | Novel pharmaceutical |
GB0031521A GB0031521D0 (en) | 2000-12-22 | 2000-12-22 | Novel pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1349855T3 true DK1349855T3 (da) | 2006-12-27 |
Family
ID=27447913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01272109T DK1349855T3 (da) | 2000-12-22 | 2001-12-21 | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt |
Country Status (12)
Country | Link |
---|---|
US (2) | US20040082620A1 (da) |
EP (1) | EP1349855B1 (da) |
JP (1) | JP2004520326A (da) |
KR (1) | KR100840846B1 (da) |
CN (1) | CN1310912C (da) |
AT (1) | ATE337313T1 (da) |
CY (1) | CY1106226T1 (da) |
DE (1) | DE60122580T2 (da) |
DK (1) | DK1349855T3 (da) |
ES (1) | ES2270955T3 (da) |
PT (1) | PT1349855E (da) |
WO (1) | WO2002051839A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
DE60217168T2 (de) * | 2001-11-21 | 2007-10-04 | Smithkline Beecham Plc, Brentford | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff |
US20060182692A1 (en) * | 2003-12-16 | 2006-08-17 | Fishburn C S | Chemically modified small molecules |
PL1694363T3 (pl) * | 2003-12-16 | 2014-07-31 | Nektar Therapeutics | Monodyspersyjne kompozycje PEGylowanego naloksolu |
DE102005034406A1 (de) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | Neue Salze von Rosiglitazon |
US7435741B2 (en) * | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
EP2062880A1 (en) | 2007-11-22 | 2009-05-27 | Bayer Schering Pharma Aktiengesellschaft | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
PL2621496T5 (pl) | 2010-09-30 | 2019-05-31 | Astrazeneca Ab | Krystaliczny koniugat naloksol-peg |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0842925A1 (en) * | 1987-09-04 | 1998-05-20 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
US5741803A (en) * | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2001
- 2001-12-21 AT AT01272109T patent/ATE337313T1/de not_active IP Right Cessation
- 2001-12-21 JP JP2002552934A patent/JP2004520326A/ja active Pending
- 2001-12-21 KR KR1020037008368A patent/KR100840846B1/ko not_active IP Right Cessation
- 2001-12-21 DK DK01272109T patent/DK1349855T3/da active
- 2001-12-21 PT PT01272109T patent/PT1349855E/pt unknown
- 2001-12-21 US US10/451,215 patent/US20040082620A1/en not_active Abandoned
- 2001-12-21 ES ES01272109T patent/ES2270955T3/es not_active Expired - Lifetime
- 2001-12-21 WO PCT/GB2001/005751 patent/WO2002051839A1/en active IP Right Grant
- 2001-12-21 CN CNB018227767A patent/CN1310912C/zh not_active Expired - Fee Related
- 2001-12-21 EP EP01272109A patent/EP1349855B1/en not_active Expired - Lifetime
- 2001-12-21 DE DE60122580T patent/DE60122580T2/de not_active Expired - Fee Related
-
2005
- 2005-08-09 US US11/199,779 patent/US7291740B2/en not_active Expired - Fee Related
-
2006
- 2006-10-31 CY CY20061101559T patent/CY1106226T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE337313T1 (de) | 2006-09-15 |
CN1491224A (zh) | 2004-04-21 |
KR100840846B1 (ko) | 2008-06-23 |
US7291740B2 (en) | 2007-11-06 |
DE60122580D1 (de) | 2006-10-05 |
CN1310912C (zh) | 2007-04-18 |
JP2004520326A (ja) | 2004-07-08 |
DE60122580T2 (de) | 2007-08-30 |
US20060040993A1 (en) | 2006-02-23 |
EP1349855B1 (en) | 2006-08-23 |
PT1349855E (pt) | 2006-12-29 |
KR20030064855A (ko) | 2003-08-02 |
CY1106226T1 (el) | 2011-06-08 |
US20040082620A1 (en) | 2004-04-29 |
ES2270955T3 (es) | 2007-04-16 |
WO2002051839A1 (en) | 2002-07-04 |
EP1349855A1 (en) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60112729D1 (de) | Hcl-salze von 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dion | |
CY1106226T1 (el) | Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης | |
CY1105354T1 (el) | Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο | |
AP1715A (en) | The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione | |
AP1814A (en) | Tartrate salts of thiazolidinedione derivative. | |
DE60212434D1 (de) | Rosiglitazon-edisylate und ihre verwendung als antidiabetika | |
AP2002002684A0 (en) | 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical | |
MXPA02012100A (es) | Sal de tiazodilindiona para el tratamiento de la diabetes mellitus. | |
DE60124119D1 (de) | Ein thiazolidindionderivat und seine verwendung als antidiabetikum | |
AP1785A (en) | Tartrate salt of thiazolidinedione derivative. | |
NO20075507L (no) | Tiazolidindionderivater og deres anvendelse som antidiabetiske midler | |
HK1068884A1 (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt | |
SI1265893T1 (sl) | Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona |